FKBP4 Accelerates Malignant Progression of Non-Small-Cell Lung Cancer by Activating the Akt/mTOR Signaling Pathway

Table 1

Correlation between clinicopathological factors and FKBP4 expression in patients with NSCLC.

Factors	Number of patients	Upregulated FKBP4	Downregulated FKBP4	value
Gender
Male	26	12	14
Female	14	8	6	0.507
Age
<65	23	12	11
≥65	17	8	9	0.749
Tumor size
<3 cm	21	6	15
≥3 cm	19	14	5	0.004
Lymph node metastasis
N0	25	9	16
N1-3	15	11	4	0.022
Grading
Low	24	11	13
Medium/advanced	16	9	7	0.519
TNM staging
I-II	27	11	16
III-IV	13	9	4	0.091
Smoking history
No	11	6	5
Yes	29	14	15	0.723

The chi-square test was used for statistical analysis.